A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders

Conditions: Neuromyelitis Optica Spectrum Disorders Interventions: Drug: Inebilizumab Sponsors: Hansoh BioMedical R&D Company; Horizon Therapeutics Ireland DAC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials